EMA updates:
Digital transformation is need of any organization.
The Heads of Medicines Agencies (HMA), the European Commission (EC), and the European Medicines Agency (EMA) have jointly released electronic product information (ePI) for selected human medicines in a groundbreaking initiative. The ePI includes essential details about a medicine, encompassing its summary of product characteristics, labelling, and package leaflet.
💡What's ePI? It includes essential details like a medicine's characteristics, labelling, and package leaflet. Traditionally in PDFs, the shift to digital platforms offers real-time updates and improved accessibility for healthcare professionals and patients.
Traditionally available as PDFs on regulatory websites, the transition to ePIs aims to enhance accessibility and real-time updates for healthcare professionals and patients.
The EU ePI Common Standard has been adopted by the European medicines regulatory network to support the provision of harmonised electronic information on medicines within the EU.
🖥️ Accessible Anywhere: ePIs are currently available in English for centrally approved medicines and local languages for nationally approved ones on the Product Lifecycle Management Portal - application programming interface .
For More Details please visit below site of EMA